About Nectar Lifesciences Ltd. (NLL)

Overview 

 

Nectar Lifesciences Ltd. (NLL) is an Indian pharmaceutical company with its head office in Chandigarh, India. Incorporated in 1995, the company manufactures and sells Cephalosporin intermediates, active pharmaceutical intermediates (APIs) and Formulations to over 65 countries worldwide, including India, EU and the US. The company also provides contract research and manufacturing services to leading pharmaceutical organizations.

 

Other Highlights:

 

  • In the FY 2015-16, the company received:
    • ANVISA-cGMP approval for its Derabassi API facility
    • Outstanding Export Performance award from Pharmexcil
    • National Energy Conservation Award (NECA) from the Govt. of India
  • #19 ranking in Indian Pharma and made it into Fortune 500 India 2013 companies
  • #357 ranking in the list of India’s top companies (Business World, Nov. 2012)
  • Trading House status (*** star export house) in 2009

 

 

Nectar Lifesciences Ltd. (NLL) is listed on the National Stock Exchange of India (NSE) and the Bombay Stock Exchange (BSE).

 

Nectar Lifesciences Ltd. (NLL) at-a-glance

 

  • Employees 2000+
  • Turnover (31 March, 2016) USD 270.33 million
  • International Footprint 65+ countries
  • Manufacturing Facilities 11
  • ANDAs Filed 15
  • DMFs Files 44

 

 

 

 

Approvals

USFDA

EUGMP INFARMED

KFDA

PMDA

MCC

ANVISA

ISO 9001:2008

ISO 14000

ISO 14001

ISO 18001

*Source:

Annual Report 2015-16

 

 

History

 

Founded in 1995, Nectar Lifesciences Ltd. (NLL) has evolved from being a manufacturer of oral and sterile APIs and fixed dosage formulations (FDFs) to a more composite pharmaceutical organization. In July 2005, the company went public with simultaneous listings on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) of India. In 2010, the company received a private equity investment of ?2.5 billion from New Silk Route (NSR).

 

Milestones

 

  • 1995 – Nectar Lifesciences Ltd. (NLL) is incorporated
  • 1997-2004 – Becomes an API manufacturer with a single facility, focusing on

 

Batalactum(Cephalosporins and SSPs), with operations in India as well as less regulated markets

 

  • 2004 – Becomes an integrated Cephalosporin manufacturer with an emphasis on tailormade research for custom synthesis related to Betalactams
  • 2006 – Launches Menthol division
  • 2007 – Commissions state-of-the-art Empty hard gelatin plant
  • 2008 – Launches Generics division
  • 2010 – Launches Diagnostics division

 

BOARD OF DIRECTORS

 

  • Chairman & Managing Director: Mr. Sanjiv Goyal
  • CEO & Wholetime Director: Mr. Dinesh Dua
  • Non-Independent and Non-Executive Director Mr. Vivek Sett
  • Independent and Non-Executive Director Dr. (Maj. Gen) SS Chauhan, VSM
  • Independent and Non-Executive Director Mr. Vijay J Shah
  • Independent and Non-Executive Director Mr. Ajay Swaroop
  • Non-Promoter and Executive Director Mr. Harparkash Singh Gill
  • Independent and Non-Executive Director Mr. Guljit Chaudhri

 

 

CORPORATE OFFICE

Nectar Lifesciences Ltd.
SCO 38-39, Sector 9-D 
Chandigarh 160009
India

 

 

Website: http://www.neclife.com/
Tel: 0172-3047777, 3047701
Fax: 0172-3047755

HEAD OFFICE

Nectar Lifesciences Ltd.
F-66, 6th Floor, Himalaya House

23 KG Marg, C.P

New Delhi-110001

India

 

Tel: 011-42403311-22
 

REGISTERED OFFICE

Nectar Lifesciences Ltd

Village Saidpura, Tehsil Derabassi,

Distt. SAS Nagar, Punjab

India

 

Tel: 01762-30800,308001

Fax: 01762-281187

 

 

 



Comment!
 
 






* Indicates mandatory field.
Please wait while comments are being sent...